JPRN-jRCT2031230623
Recruiting
未知
Special drug use-results surveillance of Tafinlar/Mekinist (BRAF-mutation-positive advanced/recurrent solid tumors(excluding colorectal cancer), CDRB436I1401)
sato masayuki0 sites90 target enrollmentFebruary 8, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- BRAF V600E mutation-positive unresectable advanced or recurrent solid tumor
- Sponsor
- sato masayuki
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who have given written consent to cooperate in this surveillance
- •2\. For patients aged \< 18 years at the start of treatment with the product, their legally authorized representative must have given written informed consent for cooperation in this surveillance prior to patient enrollment.
- •3\. Patients who start treatment with the product for BRAF\-mutation\-positive advanced/recurrent solid tumors (excluding colorectal cancer) after the approval of additional indications
Exclusion Criteria
- •1\.Patients who have received or are receiving a product containing the same ingredient as the product in any other study or research than this surveillance
- •2\.Patients with BRAF\-mutation\-positive malignant melanoma
- •3\.Patients with BRAF\-mutation\-positive non\-small cell lung cancer
- •4\.Patients with BRAF\-mutation\-positive hairy cell leukemia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Protocol Number; CINC280AJP01MET exon 14 skipping mutation-positive unresectable advanced/recurrent non-small cell lung cancerJPRN-jRCT2031200409Sugimoto Toshiya100
Recruiting
Not Applicable
Special Drug Use Results Surveillance for the use of Odefsey in pregnant womeHIV/AIDSJPRN-UMIN000034028Janssen Pharmaceutical K.K.3
Completed
Not Applicable
Special drug use results surveillance for the use of SIMPONI in ulcerative colitisulcerative colitisJPRN-UMIN000027542Janssen Pharmaceutical K.K.300
Recruiting
Not Applicable
Special drug use-results surveillance <Patients with cold agglutinin disease>Cold agglutinin diseaseJPRN-UMIN000049607sanofi K.K.100
Recruiting
Not Applicable
Special Drug Use Surveillance in Tamiflu-Resistant Influenza VirusesInfluenza type A or B virus infectionJPRN-UMIN000038553Chugai Pharmaceutical Co. Ltd.200